4f7b: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
[[Category: Neculai, D.]] | [[Category: Neculai, D.]] | ||
[[Category: Neculai, M.]] | [[Category: Neculai, M.]] | ||
[[Category: Pizzaro, J.]] | [[Category: Pizzaro, J C.]] | ||
[[Category: Ravichandran, M.]] | [[Category: Ravichandran, M.]] | ||
[[Category: SGC, Structural Genomics Consortium.]] | [[Category: SGC, Structural Genomics Consortium.]] | ||
[[Category: Seitova, A.]] | |||
[[Category: Atherosclerosis]] | [[Category: Atherosclerosis]] | ||
[[Category: Cell adhesion]] | [[Category: Cell adhesion]] | ||
Revision as of 05:12, 23 October 2013
Structure of the lysosomal domain of limp-2
Disease
[SCRB2_HUMAN] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.
Function
[SCRB2_HUMAN] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.[1]
About this Structure
4f7b is a 6 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007 Nov 16;131(4):770-83. PMID:18022370 doi:https://dx.doi.org/10.1016/j.cell.2007.10.018
